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A B S T R A C T
Obesity is a disease characterized by an excessive accumulation of fat in the body and it has been linked the
enhancement of inflammation-related endogenous molecules, such as adenosine (AD). Since blueberries may
induce anti-obesity effects, we tested the hypothesis that blueberries consumption contained in hypocaloric diet
would decrease weight, BMI as well as glucose, cholesterol, triglycerides and AD levels in obese subjects. The
baseline conditions of obesity-related variables were collected for all subjects prior the implementation of
blueberries intake. Later, participants received a hypocaloric diet that included the consumption of blueberries
(50 g/day) during 30 days. We found that male obese subjects that consumed blueberries showed a decrease in
weight, glucose, cholesterol, triglycerides and AD whereas female obese subjects that ate blueberries in hypo-
caloric diet showed no differences in weight, BMI, glucose and triglycerides but displayed a diminution in
cholesterol and AD levels. Data suggest that intake of blueberries seems to decrease some of the obese-linked
parameters in male or female subjects. Importantly, blueberry consumption decreased the inflammation-related
compound AD in both sexes.
1. Introduction
Obesity is a health disturbance characterized by multiple symptoms,
including excessive accumulation of fat in the body, as well as high
body mass index (BMI) (> 30 Kg/m2; WHO, 2012). In addition, obesity
is linked with several health problems, such as hypertension, type 2
diabetes, and cancer, just to mention a few. Moreover, obesity causes
the enhancement of pro-inflammatory-related compounds including
adenosine (AD) (Kaysen, 2009; Pandolfi et al., 2015; Rabkin &
Campbell, 2015). One clinical approach to control obesity is the use of
specific diets. In line with this, several fruits included in the diet have
been associated with health benefits. For example, blueberries contain
antioxidant polyphenols that seem to control obesity and inflammation
processes (Burton-Freeman, Sandhu, & Edirisinghe, 2016; Jakobsdottir
et al., 2013; Jiao et al., 2018; Lee et al., 2016; Liu et al., 2017; Noratto,
Chew, & Ivanov, 2016; Wu, Gao, Guo, Zhang, & Gong, 2018).
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Nevertheless, as the beneficial health-promoting effects of blueberries
on obesity and AD levels remains to be determined. Thus, the present
study investigated whether consumption of blueberries included in a
hypocaloric diet and given to obese subjects may decrease anthropo-
metric measurements such as weight and BMI and exert positive effects
on dysregulated glucose, cholesterol, and triglycerides and AD levels.
2. Materials and methods
2.1. Bioethical considerations
The Committee for Research and Bioethics of our Institution ap-
proved the experimental protocol. During the development of the study,
personal information was ensured to be used strictly for the purposes of
the analysis of data. In addition, the management of biological samples
followed the Guidelines of the Official Mexican Norm (NOM-253-SSA1-
2012) as well as the Guidelines of Hazardous Waste Management
Biological-Infectious (derived from the Mexican Official Norm [NOM-
087-ECOL-SSA1-200]). Furthermore, the study was conducted in ac-
cordance with the World Medical Association (Declaration of Helsinki)
considering the subjects' approved participation by a written informed
consent. The data were analyzed anonymously throughout the study.
2.2. Participants
2.2.1. Recruitment
We recruited participants by using advertisements in the
Universidad Anáhuac Mayab (students and staff), and by word-of-
mouth.
2.2.2. Screening and inclusion
We screened interested volunteers over the telephone and/or social
media (email, Facebook, WhatsApp) to be scheduled for the first in-
terview. In session 1, they met with the principal investigator and re-
search staff who gave them a written and verbal detailed description of
the research to assess their willingness to participate. Prior to the
comprehensive screening assessment, the informed consent was ob-
tained from all participants if they met the inclusion criteria.
2.2.3. Inclusion criteria for participants
To be eligible for inclusion in the study, participants met the obesity
criteria (Body Mass Index [BMI]; ≥30 Kg/m2). Therefore, subjects
were scheduled for Session 2 (09:00 h) to collect anthropometric mea-
surements such as weight and BMI at the Nutrition Clinic at
Universidad Anáhuac Mayab using a body composition analyzer
(INBODY®, Body Composition Analyzer, model Inbody 720. Korea,
Japan). The procedures used in this section of the study met the in-
ternationally accepted criteria (Cáceres-Medina et al., 2015; WHO,
2012). The anthropometric variables collected from Session 2 were
considered as baseline condition (pre-diet). Exclusion criteria included
self-report of volunteers having previous or recent diagnosis of cancer,
endocrine disorders, higher blood pressure (> 140/90mm Hg), dia-
betes mellitus, inflammatory, autoimmune disorders, or similar dis-
eases. In addition, female participants were excluded if they were
pregnant or lactating. Self-reported medical conditions such as anxiety,
chronic pain, sleep disturbances, and depression, under pharmacolo-
gical prescription or drug (alcohol, other substances) use were also
conditions considered as exclusion criteria.
2.2.4. Participants
From the total participants (n=40, men; n=20, women), only
those who successfully completed the study were included in the report
(> 18 years old; men [n=5] and women [n=9]). Those who did not
complete the study (men [n=35] and women [n= 11]) were excluded
from final report since they failed to follow the diet. Study completers
were from Metropolitan area of Mérida City and self-identified as
Hispanic.
2.3. Chemicals
Reagents, chemicals, and materials were purchased from Sigma-
Aldrich (St Louis, MO. USA).
2.4. Interventions
The study design flow chart is shown in Fig. 1. In detail: Participants
(men [n=5] and women [n=9]) were diagnosed in Session 2
(baseline condition: Pre-diet) as obese according to the World Health
Organization criteria for BMI (Oviedo-Solís, Cornejo-Manzo, & Murillo-
Ortiz, 2018). The Session 2 included the collection of anthropometric
measurements (see section Anthropometric Measurements), and bio-
chemical sampling (see section Blood sampling collection). Moreover, in
this session, the estimation of total energy expenditure was determined
(see section Estimation of the Total energy expenditure) and the hypoca-
loric diet was given to the participants (see section Hypocaloric diet with
blueberries consumption). Thirty days later, volunteers were appointed
once again for Session 3 (treatment: Post-diet with blueberries con-
sumption) at 09:00 h to obtain anthropometric measurements as well as
blood sample collection.
2.4.1. Anthropometric measurements
The weight was calculated by using a standardized balance whereas
BMI (BMI≥ 30 Kg/m2) was obtained by dividing weight by squared
height (Kg/m2) using a body composition analyzer (INBODY®, Body
Composition Analyzer, Inbody 720. Korea, Japan). The procedures used
Fig. 1. Schematic representation of the experimental design used in the current
report.
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in this section of the study were developed as previously reported
(Cáceres-Medina et al., 2015; Houska et al., 2018). All measurements
were obtained from all participants at Session 2 (baseline condition:
Pre-diet) and Session 3 (treatment: Post-diet with blueberries con-
sumption). All the equipments used for obtaining weight and BMI were
calibrated after every single measurement for each subject.
2.4.2. Blood sampling collection
Once obtaining the anthropometric measurements from partici-
pants, blood was collected (6mL) into pyrogen-free tubes (Vacutainer
TM, BD Diagnostics, NJ. USA) containing EDTA anticoagulant (Sigma
Chemicals; St. Louis, MO. USA). Later, blood was centrifuged (1000g/
4 °C) for 30min, and serum samples were obtained and stored (−80 °C)
until analysis. This procedure was developed in Session 2 (baseline
condition: Pre-diet) and Session 3 (treatment: Post-diet with blueberries
consumption) following previous reports (Cáceres-Medina et al., 2015).
2.4.3. Estimation of the total energy expenditure (TEE)
To design the diet plan, TEE was determined by the number of Kcal
that subjects consumed using the indirect calorimetric measurement
(KORR, Reevue. Salt Kale, UT. USA) estimating the rest energy ex-
penditure [REE]). This procedure was used as previously reported by
other groups (Cáceres-Medina et al., 2015; Houska et al., 2018;
Steinberg et al., 2017).
2.4.4. Hypocaloric diet including blueberries intake
In Session 2 (baseline condition: Pre-diet), a dietary guidance was
provided to subjects consisting in a hypocaloric diet (reduction of
500 kcal of total energy requirement) with a distribution of macro-
nutrients as follows: Carbohydrates 50%, protein 22% and fat 28%. The
diet was applied during 30 days and it was based on previous reports
(Benito et al., 2015; Cáceres-Medina et al., 2015; Houska et al., 2018;
Steinberg et al., 2017).
Literature suggests that blueberries consumption has been asso-
ciated with amelioration of obesity as well as diminution of obesity-
related pro-inflammatory molecules (Badillo et al., 2017; Burnstock &
Gentile, 2018; Cáceres-Medina et al., 2015; Margalef et al., 2017;
Noratto et al., 2016; Oviedo-Solís, Cornejo-Manzo, & Murillo-Ortiz,
2018; Pandolfi et al., 2015; Wyckoff, Evans, Manasse, Butryn, &
Forman, 2017). Thus, we included blueberries as beneficial health-
promoting food in hypocaloric diet as suggested by others (Wu, Yang,
et al., 2018; Zhang, Ma, Luo, & Li, 2018). Therefore, to evaluate whe-
ther a pathological state of obesity would be influenced by blueberries
consumption (50 g/day), this food item was included in the group of
subjects. Lastly, reminders of the diet were made to all subjects through
phone calls once a week across the duration of the study.
2.5. Blood sample collection and determination of glucose, cholesterol,
triglycerides
Blood sample procedure was developed according to standardized
medical practices in Session 2 (baseline condition: Pre-diet) and Session
3 (treatment: Post-diet with blueberries consumption) following pre-
vious reports (Cáceres-Medina et al., 2015). The blood samples were
obtained as follows: The subjects were seated in a chair for veni-
puncture, while resting both arms. In order to collect blood properly,
the site to be punctured was selected avoiding areas such as bruises,
burns, or scars, and one of the veins to be punctured was visually
identified (ulnar, cephalic or basilic). Once the vein was identified and
selected, a tourniquet 3–4 in. above the selected site was placed on the
subject's arm (indistinct). The tourniquet remained for a time no longer
than 5min. Subsequently, the area to be punctured was decontami-
nated with 70% ethyl or isopropyl alcohol using a cotton swab. To
perform the blood extraction, the arm preferably remained horizontal,
the subject was requested to open, and close the fist 3–5 times to pump
blood, and then keep the fist closed. Subsequently, the tip of the needle
was placed at an angle of 15–30 degrees on the surface of the chosen
vein and the needle was inserted with a firm movement into the lumen
of the vein. The blood was collected until required volume was obtained
(6mL). The blood samples were used to analyze glucose, cholesterol,
and triglyceride levels by following standard procedures (Kaysen, 2009;
Tucková et al., 2017). Blood sample procedure was developed in Ses-
sion 2 (baseline condition: Pre-diet) and Session 3 (treatment: Post-diet
with blueberries consumption) following previous reports (Cáceres-
Medina et al., 2015).
2.6. Measurement of adenosine levels by HPLC
The blood samples collected in Session 2 (baseline condition: Pre-
diet) and Session 3 (treatment: Post-diet with blueberries consumption)
were processed for analysis of contents of AD using the high-perfor-
mance liquid chromatography (HPLC; Modular Prominence HPLC,
Shimadzu. Japan). The separation of molecule was achieved by using a
C18 column (5 μm, 150×4.6mm; Restek. Bellefonte, PA. USA) within
controlled temperature (35 °C; oven CTO-20A. Shimadzu. Japan). The
detection of AD was obtained by using an UV detector (260 nm; SPD-
20A Prominence. Shimadzu. Japan) coupled to HPLC. The mobile phase
(20mM of ammonium acetate, pH 5.8: methanol [97.5:2.5]) was per-
fused (flow rate 1mL/min) using a pump (LC-20AT. Prominence HPLC,
Shimadzu. Japan). The samples were automatically injected (SIL-20A
HT Prominence HPLC, Shimadzu. Japan) and chromatographic data
was stored in a personal computer (via computer controller. CBM-20A.
Shimadzu. Japan). The levels of AD were calculated by using the HPLC
software (LC LabSolution. Shimadzu. Japan) comparing the sample
peaks with known external standards. The procedure for analysis of the
concentrations of AD was carried out as previously reported as well as
by manufacturer's suggestions (Cáceres-Medina et al., 2015; Murillo-
Rodríguez et al., 2017).
2.7. Statistical analysis
The results are represented as mean ± standard error of the mean.
To determine whether blueberries intake would induced changes in
weight, BMI, glucose, cholesterol, triglycerides as well as AD levels,
variables were compared between baseline and blueberries consump-
tion condition. Statistical differences were identified by a Student t–test
with a significance level of P < 0.05. All statistical analyses were de-
termined using StatView (version 5.0.0; SAS Institute. USA).
3. Results and discussion
3.1. Male anthropometric, biochemical and AD measurements in pre-diet vs
male post-diet with blueberries consumption
Table 1 shows that comparison between male pre-diet vs male post-
diet with blueberries consumption displayed statistical differences in
weight (P < 0.05) whereas BMI did not show significant changes
Table 1
Weight, BMI, glucose, cholesterol, triglycerides and adenosine measurements
from male pre-diet vs. male post-diet with blueberries consumption.
Male pre-diet Male post-diet with
blueberries consumption
P-value
Weight (Kg) 93.20 ± 2.4 80.26 ± 2.0 P < 0.05
BMI (Kg/m2) 30.64 ± 1.3 29.26 ± 1.3 P=0.4
Glucose (mg/dL) 92.04 ± 3.7 83.14 ± 1.6 P < 0.05
Cholesterol (mg/
dL)
210.45 ± 14.1 152.70 ± 6.6 P < 0.006
Triglycerides (mg/
dL)
190.69 ± 54.7 112.16 ± 2.4 P < 0.05
Adenosine 257.66 ± 170.1 70.61 ± 5.8 P < 0.0005
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(P= 0.4). However, it is worthy to mention that glucose (P < 0.05),
cholesterol (P < 0.006) and triglycerides (P < 0.05) levels were di-
minished after blueberries consumption. Importantly, we found that
intake of blueberries contained in a hypocaloric diet caused a decrease
in AD levels in male obese subjects (P < 0.0005).
3.2. Female anthropometric, biochemical and AD measurements in pre-diet
vs female post-diet blueberries intake
Comparison of anthropometric variables in female obese subjects
before and after blueberries intake showed no significant differences
were found in weight (P=0.8), BMI (P=0.7), glucose (P= 0.5) and
triglycerides (P= 0.9). However, cholesterol was decreased (P < 0.05)
as well as AD levels (P < 0.0001) (see Table 2).
Dietary plans replacing high caloric food items have become a
clinical approach for treating obesity. However, diet plan changes show
limited successful outcomes (Amiot, Riva, & Vinet, 2016; Asghari,
Mirmiran, Yuzbashian, & Azizi, 2017; Curioni & Lourenco, 2005;
Lichtenstein et al., 2014; Martin & Gadde, 2014; Moosavi, Hosseini,
Saso, & Firuzi, 2016; Noratto et al., 2016; Rabkin & Campbell, 2015).
The positive impact on obese-related measurements by including the
consumption of blueberries in diets has opened a new horizon revealing
the putative role of these fruits consumption in endogenous obesity-
related molecules (Burton-Freeman et al., 2016; Jakobsdottir et al.,
2013; Lee et al., 2016; Liu et al., 2017; Noratto et al., 2016; Oviedo-
Solís, Cornejo-Manzo, & Murillo-Ortiz, 2018). In this study, we ex-
amined the hypothesis that consumption of blueberries included in
hypocaloric diet given to obese subjects would decrease anthropometric
measurements, biochemical elements as well as the pro-inflammatory
molecule AD.
A dietary pattern comprising hypocaloric restriction as well as
blueberries (50 g/day/30 days) caused differences in male weight,
glucose, cholesterol, triglycerides and AD whereas BMI remained with
no significant changes compared to pre-diet condition. On the other
hand, female obese subjects that consumed blueberries in hypocaloric
diet showed no statistical differences in weight, BMI, glucose and tri-
glycerides while cholesterol and AD levels were decreased. We spec-
ulate that differences in effects observed in experimental variables such
as weight, BMI, glucose and triglycerides between sexes might be re-
lated with metabolic aspects proper of male or female subjects
(Dearden, Bouret, & Ozanne, 2018; Barstad et al., 2018).
The current results are in line with previous reports by showing the
positive effects of consuming berries in obesity control as well as in
decreasing inflammatory-related molecules (Kowalska, Olejnik,
Szwajgier, & Olkowicz, 2017; Leu et al., 2017; Noratto et al., 2016;
Vendrame, Tsakiroglou, Kristo, Schuschke, & Klimis-Zacas, 2016; Wu
et al., 2013; Wu, Yang, et al., 2018). In this regard, rat models of obesity
respond positively if animals are under diet enriched with blueberries
(Aranaz et al., 2017). Similar outcome shave been reported in obese
humans suggesting that functional foods such as blueberries exert po-
sitive effects in obese-related parameters (Basu et al., 2010; Novotny,
Baer, Khoo, Gebauer, & Charron, 2015; Stull, Cash, Johnson,
Champagne, & Cefalu, 2010).
However, some limitations from current report are important to
mention. For example, we recognize that number of subjects reported in
our study could represent a limitation. In this regard, it is assumed that
participants in clinical research are responsible for following the
agreement when they accept to be enrolled in a study. These respon-
sibilities of fulfilling instructions are based on promise-keeping.
However, participants also have the right of withdrawal at any time and
without giving any reason and research staff are unable to “push”
subjects to remain in the study by any mean (Schaefer & Wertheimer,
2010; Resnik & Ness, 2012; Hug & Johansson, 2017). Perhaps in future
trials using financial incentives, subjects might remain for meeting
study requirements. In addition, we are aware about the likely influ-
ence of hormonal status in our study in female subjects that might affect
the metabolism as reported by others (Bryant, Truesdale, & Dye, 2006).
Thus, next studies should include hormonal control in female subjects.
Another limitation identified includes the unknown mechanism of ac-
tion of some of the compounds contained in blueberries, such as the
polyphenols on weight, BMI, glucose, cholesterol, triglycerides and AD.
Indeed, future reports should aim the description of the polyphenols in
modulation of obese-related biomedical parameters. In this regard,
nutritional effects caused by blueberries seem to be related with fla-
vonoids. Several pieces of evidence have suggested that consumption of
fruits containing flavonoids exert a positive effect in obesity. Based in
the evidence, one might hypothesize that intake of blueberries may
exert anti-inflammatory effects by increasing the degradation of AD,
compound that has been involved in the pathophysiology of obesity
(Babu, Liu, & Gilbert, 2013; Gentile et al., 2018; Singh & Venkatesan,
2018). Thus, the effects of blueberries consumption in the synthesis
and/or degradation of AD in obese subjects should be addressed as well.
Moreover, it remains to be elucidated if the effects on obesity-related
variables induced by blueberries consumption are long-term. Moreover,
it is possible that additional biochemical elements related to in-
flammation and glucose metabolism, including cytokines, might be
under the influence of blueberry supplementation (Gonzalez, Garrie, &
Turner, 2018; Kern, Mittenbühler, Vesting, Ostermann, Wunderlich, &
Wunderlich, 2018; Zhou, Li, & Pathak, 2019). Future studies should
address whether contents of TNFα and IL6 in obese subjects respond to
blueberry intake in diet.
4. Conclusions
In this study, we found that consumption of blueberries in male
obese subjects decreased weight, glucose, cholesterol, triglycerides as
well as AD levels whereas female obese subjects displayed no statistical
changes in weight, BMI, glucose, and triglycerides but decreased AD
contents. This study could provide preliminary evidence regarding the
effects of consuming blueberries as part of a diet given to obese sub-
jects.
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